```

[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Page 103848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30321]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below in 
advance of the meeting. The meeting can be accessed from the NIH 
Videocast at the following link: http://videocast.nih.gov/.
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Date: February 13, 2025.
    Open: 10:00 a.m. to 1:10 p.m.
    Agenda: NCAB Subcommittee Meetings.
    Open: 1:15 p.m. to 4:05 p.m.
    Agenda: Director's and Program reports and presentations; 
business of the Board.
    Closed: 4:15 p.m. to 5:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Paulette S. Gray, Ph.D., Director Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Institute's/Center's home 
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm, 
where an agenda, instructions for accessing the virtual NCAB meetings, 
and any additional information for the meetings will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-30321 Filed 12-18-24; 8:45 am]
BILLING CODE 4140-01-P
```